Funding
Maudsley
The study was funded by the Lilly Pharmaceuticals and the Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Psychology and Neuroscience, King’s College London. Lilly and NIHR BRC had no input into the design of the study; in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the paper for publication. KR has received speaker’s honoraria from Shire, Medice, and Lilly.